Marketing-authorisation holder
Teva Canada Limited
1,484 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder
1,484 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 1,484
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETAMINOPHEN325 mg · Tablet | Paracetamol | Canada | Authorised | |
| ACETAMINOPHEN EXTRA STRENGTH500 mg · Tablet | Paracetamol | Canada | Authorised | |
| ACETAMINOPHEN WITH CODEINE - CAPLET300 mg + 15 mg + 8 mg · Tablet | Paracetamol, Caffeine, Codeine | Canada | Marketed | 1997 |
| ACT BORTEZOMIB3.5 mg / vial · Powder For Solution | Bortezomib | Canada | Marketed | 2015 |
| ACT CABERGOLINE0.5 mg · Tablet | Cabergoline | Canada | Not marketed | 2007 |
| ACT CIPROFLOXACIN250 mg · Tablet | Ciprofloxacin | Canada | Marketed | 2004 |
| ACT CIPROFLOXACIN750 mg · Tablet | Ciprofloxacin | Canada | Marketed | 2004 |
| ACT CIPROFLOXACIN500 mg · Tablet | Ciprofloxacin | Canada | Marketed | 2004 |
| ACT ENALAPRIL8 mg · Tablet | Enalapril | Canada | Marketed | 2007 |
| ACT ENALAPRIL4 mg · Tablet | Enalapril | Canada | Marketed | 2007 |
| ACT ENALAPRIL16 mg · Tablet | Enalapril | Canada | Marketed | 2007 |
| ACT ENALAPRIL2 mg · Tablet | Enalapril | Canada | Marketed | 2007 |
| ACT ESCITALOPRAM ODT20 mg · Tablet (Orally-Disintegrating) | Escitalopram | Canada | Marketed | 2016 |
| ACT ESCITALOPRAM ODT10 mg · Tablet (Orally-Disintegrating) | Escitalopram | Canada | Marketed | 2016 |
| ACT EXEMESTANE25 mg · Tablet | Exemestane | Canada | Marketed | 2012 |
| ACT FAMCICLOVIR250 mg · Tablet | Famciclovir | Canada | Not marketed | 2008 |
| ACT FAMCICLOVIR125 mg · Tablet | Famciclovir | Canada | Not marketed | 2008 |
| ACT FAMCICLOVIR500 mg · Tablet | Famciclovir | Canada | Not marketed | 2008 |
| ACT FLUCONAZOLE50 mg · Tablet | Fluconazole | Canada | Marketed | 2007 |
| ACT FLUCONAZOLE100 mg · Tablet | Fluconazole | Canada | Marketed | 2007 |
| ACT MEMANTINE5 mg · Tablet | Memantine | Canada | Authorised | |
| ACT MEMANTINE10 mg · Tablet | Memantine | Canada | Marketed | 2010 |
| ACT METHYLPHENIDATE ER36 mg · Tablet (Extended-Release) | Methylphenidate | Canada | Marketed | 2017 |
| ACT METHYLPHENIDATE ER54 mg · Tablet (Extended-Release) | Methylphenidate | Canada | Marketed | 2017 |
| ACT METHYLPHENIDATE ER27 mg · Tablet (Extended-Release) | Methylphenidate | Canada | Marketed | 2017 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 1,484 | 708 | 776 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.